r Ex vivo proliferated c-Kit + endogenous cardiac progenitor cells (eCPCs) obtained from mouse and human cardiac tissues have been reported to express a wide range of functional ion channels.
r In contrast to previous reports in cultured c-Kit + eCPCs, we found that ion currents were minimal in freshly isolated cells. However, inclusion of free Ca 2+ intracellularly revealed a prominent inwardly rectifying current identified as the intermediate conductance Ca 2+ -activated K + current (KCa3.1)
r Electrical function of both c-Kit + eCPCs and bone marrow-derived mesenchymal stem cells is critically governed by KCa3.1 calcium-dependent potassium channels.
r Ca 2+ -induced increases in KCa3.1 conductance are necessary to optimize membrane potential during Ca 2+ entry. Membrane hyperpolarization due to KCa3.1 activation maintains the driving force for Ca 2+ entry that activates stem cell proliferation.
Introduction
Since the early 2000s, pools of endogenous cardiac progenitor cells (eCPCs) have been identified in hypoxic niches within adult hearts (Beltrami et al. 2003; Castaldo et al. 2008; Di Meglio et al. 2010) . Indeed, several distinct eCPC populations have been identified based on their intrinsic properties and markers (MDR-1, c-Kit, Sca-1, Islet-1, SSEA-1, W8B2, ALDH, Peg3/PW1) (Hierlihy et al. 2002; Beltrami et al. 2003; Oh et al. 2003; Martin et al. 2004; Laugwitz et al. 2005; Chimenti et al. 2012; Sandstedt et al. 2014; Zhang et al. 2015; Yaniz-Galende et al. 2017) . c-Kit + eCPCs represent the best-characterized eCPC population and have been identified in the hearts of a range of species including humans (Bearzi et al. 2007; van Vliet et al. 2008; Sandstedt et al. 2012) , dogs (Linke et al. 2005) , pigs (Ellison et al. 2011) , sheep (Hou et al. 2012) , cats (Angert et al. 2011) , rats (Beltrami et al. 2003) , mice and zebrafish (Ellison et al. 2013; Verduci et al. 2014) . Clonogenic, self-renewing, multipotent c-Kitexpressing cells can be harvested from adult hearts (Beltrami et al. 2003; Linke et al. 2005; Bearzi et al. 2007 ). c-Kit + eCPCs are reported to constitute approximately 0.01% of cardiomyocytes in the adult rat heart (Beltrami et al. 2003) and have been shown to differentiate into all three cardiovascular lineages (endothelial cells, vascular smooth muscle cells and cardiomyocytes) in vitro under specific conditions (Beltrami et al. 2003; Linke et al. 2005) . While c-Kit + eCPCs have been suggested to play a role in cardiac adaptation and regeneration following myocardial stress (Nadal-Ginard et al. 2014) , recent evidence suggests that they minimally contribute cardiomyocytes under basal conditions or after cardiac injury (van Berlo et al. 2014; Sultana et al. 2015) . Although the exact biological function of c-Kit + eCPCs remains controversial in the field of cardiac regeneration, c-Kit + cell therapy or in situ mobilization of c-Kit + eCPC pools have been shown to improve heart function by promoting cardiac repair (Dawn et al. 2005; Linke et al. 2005; Fischer et al. 2009; Angert et al. 2011; Li et al. 2011) . The mechanisms of benefit of stem and progenitor cell transplantation remains poorly defined. Paracrine mechanisms have been proposed to explain the reparative and regenerative actions of transplanted cells, including exosome-mediated effects on pre-existing myocardium (Sahoo & Losordo, 2014; Khan et al. 2015) and cell-specific protein modifications (Wei et al. 2015) . Despite their potential value in regenerative therapy and the possible functional role of c-Kit + eCPCs in health and diseases, their cellular physiology needs to be better understood.
In a variety of non-excitable cell types including stem and progenitor cells, ion channels are involved in migration, proliferation and differentiation (Pardo, 2004; Lang et al. 2007; Lehen'kyi et al. 2007) . Various K + channels are implicated in regulating progenitor cell cycle progression, cellular growth and phenotypic transition (Pardo, 2004; Tao et al. 2008) . Expanded c-Kit + eCPCs obtained from mouse and human cardiac tissues have been reported to express a wide range of functional ion channels. Han et al. (2010) reported three ion currents in expanded microbead-purified mouse cardiac c-Kit + cells, including a delayed-rectifier current I KDR (likely encoded by Kv1.1, Kv1.2 or Kv1.6), an inwardly-rectifying current I Kir (probably encoded by Kir1.1, Kir2.1 or Kir 2.2) and a volume-dependent Cl − current I Cl.vol (encoded by Clcn3), present in 29%, 13% and 44% of cells respectively. More recently, Zhang et al. (2014) reported the presence of the large-conductance Ca 2+ -dependent K + current BKCa (86% of cells; encoded by KCa1.1), transient-outward current I to (47%; encoded by Kv4.2 or Kv4.3), I Kir (84%; encoded by Kir2.1) and tetrodotoxin-sensitive Na + current I Na.TTX (61%; probably encoded by Nav1.3 or Nav1.6) in cultured c-Kit + eCPCs isolated from human atrial appendages. BKCa inhibition decreased cell cycling and mobility in human c-Kit + eCPCs, whereas I Kir blockade increased cell mobility without affecting cycling. It has also been shown that functional TRPV2 and TRPV4 channels are abundantly expressed in human cardiac c-Kit + cells (Che et al. 2016) . Both channels are involved in cell migration, whereas only TRPV2 participates in regulating cell cycle progression (Che et al. 2016) . Ferreira-Martins et al. (2009) 
demonstrated that c-Kit
+ human cardiac progenitor-cell growth and regenerative potential depend upon intracellular Ca 2+ oscillations mediated by inositol-trisphosphate receptors. One major limitation of all these studies was that ion currents and corresponding gene expression were determined in expanded c-Kit + eCPCs, but not in freshly isolated cells. Because cell culture conditions can alter cellular phenotype (Dawson et al. 2012) , the electrophysiological profile of these cells might not reflect their ionic properties in situ.
Here, we characterize for the first time the ion currents in freshly isolated c-Kit + eCPCs and address their function. Our results suggest a prominent role for KCa3.1 channels in controlling eCPC membrane potential and proliferative function. Furthermore, we extend our observations to bone marrow-derived (BM) mesenchymal stem cells (MSCs). Our findings indicate an important role of KCa3.1 channels in stem cell biology, which may be susceptible to manipulation to enhance therapeutic benefits.
Methods

Ethical approval
All animal handling, surgical and post-surgical procedures followed the Guidelines of the National Institutes of Health and were approved by the Animal Research Ethics Committee of the Montreal Heart Institute. Experiments were conducted on random source adult mongrel dogs of both sexes (supplier name available upon request from the corresponding author) fed a standard diet ad libitum. Because this study focuses exclusively on cells derived from the left ventricle, the atria were removed and used for other projects to maximize the use of animals. A total of 26 dogs were used in the current study (15 males, 11 females). Studies in dogs form a vital part of biomedical research as they are amongst the animal models known to recapitulate best many of the features of the human heart, including clinical heart failure phenotypes of various aetiologies (Camacho et al. 2016) . The investigators involved in this study understand the ethical principles under which the Journal of Physiology operates and their work complies with the principles and regulations described by Grundy (2015) .
Primary cell isolation and culture
Adult mongrel dogs (30 ± 4 kg) were anaesthetized with morphine (2 mg kg −1 S.C.) and α-chloralose (120 mg kg −1 I.V., followed by 30 mg kg −1 per hour) and ventilated mechanically. Prior to heart excision, animals were deeply anaesthetised (all reflex activity and pain responses suppressed) with sodium pentobarbital (30 mg kg
and killed by exsanguination. Hearts were extracted via median thoracotomy and immediately immersed in cold oxygenated Tyrode solution. Left ventricles (LVs) were subjected to enzymatic digestion for cell isolation. The LV anterior wall was arterially perfused with Tyrode solution (see composition below) containing collagenase type II (120 U ml −1 ; Worthington, Lakewood, NJ, USA) and 0.1% bovine serum albumin (BSA). The dissociated cells were collected and dispersed by gentle trituration in cold Kraftbruhe solution. Cell suspensions were centrifuged twice at 60 g for 2 min to pellet cardiomyocytes. The supernatant was collected and filtered through a 40-μm cell strainer and centrifuged at 600 g for 5 min to pellet the cell fraction containing small mononucleated cells including c-Kit + eCPCs. Pelleted cells were resuspended (Beltrami et al. 2003; French & Davis, 2014) . Cell suspensions were initially incubated with anti-c-Kit primary antibody for 20 min at 4°C. Cells were then rinsed with cooled DPBS and incubated with sheep anti-mouse secondary antibody conjugated with superparamagnetic beads for an additional 10 min at 4°C with gentle agitation. To remove unlabelled cells (c-Kit − ), cell suspensions were placed on a magnetic particle concentrator (MPC-1) and washed three times with complete culture medium consisting of a mixture of 65% Iscove's Modified Dulbecco's Medium (IMDM)/35% DMEM-F12 containing 10% FBS, 100 U ml -1 penicillin, 100 μg ml −1 streptomycin, 2 mmol l −1 L-glutamine, 0.2 mmol l −1 2-mercaptoethanol, 10 ng ml −1 human basic fibroblast growth factor, 10 ng ml −1 human epidermal growth factor and 10 ng ml −1 human Leukemia Inhibitory Factor (LIF). The freshly collected c-Kit + cells were used for immunocytochemistry, ion channel studies and gene expression assays. c-Kit + eCPCs were also expanded in vitro for proliferation assays. c-Kit + eCPCs were cultured as previously described with slight modifications . Briefly, c-Kit + eCPCs were seeded on fibronectin (FN)-coated (20 μg ml −1 ) six-well plates in complete culture medium and cultured at 37°C in 5% CO 2 . The medium was changed the next day to remove debris and cultures were continued until cells reached 70-80% confluency (14-21 days). To ensure the availability of a sufficient number of cells for subsequent experiments, c-Kit + eCPCs were lifted and re-plated in 100 mm FN-coated culture dishes for an additional week to allow expansion. Cells used in this study were from passages 2-4 to limit potential phenotypic drift.
OriCell dog BM-MSCs were purchased from Cyagen (Santa Clara, CA, USA) and cultured according to the manufacturer's recommendations. Cells used in this study were from early passages (4-8) to limit the possible variations in functional ion channel induced by cell ageing and senescence in later passages.
siRNA transfection procedure
Canine ventricular c-Kit + eCPCs were transfected with 100 nmol l −1 siRNA (SMARTpool siGENOME KCNN4-siRNA; GE Dharmacon, Lafayette, CO, USA) or negative control construct with lipofectamine RNAi MAX reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. Cells were used for functional experiments or collected for total RNA or purification 48 h after the transfection. 
Congestive heart failure (CHF) dog model
The animal model was prepared as previously described in detail (Shinagawa et al. 2002) . Adult mongrel dogs were anaesthetized with diazepam (0.25 mg kg days (enrofloxacin, 5 mg kg −1 per os (PO) per day) to reduce the chance of infection. Following 24 h of recovery, ventricular pacing was initiated at 240 beats min −1 . After 2 weeks of continuous pacing, CHF was confirmed by signs (lethargy, dyspnoea and oedema) and in vivo haemodynamic findings before animals were killed as described above. Hearts were then excised and LVs were subjected to enzymatic digestion. All the animals included in this study completed the protocol.
Immunostaining
Freshly isolated c-Kit + eCPCs and unsorted cardiac cells (non-myocyte fraction) were seeded on fibronectin-coated (20 μg ml -1 ) eight-well chamber slides with complete growth medium, and incubated for 6 h at 37°C in 5% CO 2 to allow attachment. Cells were washed three times with warm Hanks' balanced salt solution (HBSS) before fixation (4% paraformaldehyde in HBSS for 10 min at room temperature). Cells were washed three times and then blocked for 30 min with normal donkey serum (10% in HBSS) at room temperature. c-Kit + eCPCs and unsorted cardiac cells were incubated overnight at 4°C with a rabbit anti-c-Kit antibody (1:100; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), followed by donkey anti-rabbit IgG-Alexa Fluor 555 (1:500; Invitrogen) and DAPI (1:1000; Invitrogen) for 1 h at room temperature. The next day, fluorescence images were obtained with an LSM-710 inverted confocal laser scanning microscope.
Real-time quantitative reverse transcription PCR (qPCR)
Freshly isolated c-Kit + eCPCs were resuspended in lysis buffer, and RNA was isolated with a Quick-RNA MicroPrep (Zymo Research, Irvine, CA, USA), including DNase treatment to prevent genomic contamination. Messenger RNAs were reverse-transcribed with the High-Capacity Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). qPCR was performed with TaqMan probes or SyBr green primers from Applied Biosystems for housekeeping genes hypoxanthine phosphoribosyltransferase (HPRT), β2-microglobulin (β2M) and glucose-6-phosphate dehydrogenase (G6PD Freshly isolated c-Kit + eCPCs were seeded on fibronectincoated chamber slides with c-Kit + eCPC complete growth medium, and incubated for ß4 h to allow attachment; whereas MSCs were seeded on chamber slides with their recommended growth medium and incubated overnight to allow cell spreading. Freshly isolated c-Kit + eCPCs and expanded MSCs were loaded with Fluo-4-acetoxymethyl ester (10 μmol l −1 ; Invitrogen) in complete growth medium in the presence of Pluronic F-127 (20% solution in dimethylsulphoxide, 2.5 μg ml -1 ) for 30 min at 37°C in a humidified incubator with 95% O 2 /5% CO 2 . Chamber slides were positioned on the stage of a confocal microscope; cells were incubated with Ca 2+ -free Tyrode solution and maintained for 15 min at room temperature before experimental protocols to MA, USA). Horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch Inc., West Grove, PA, USA) were used and immunoreactive bands were revealed by chemiluminescence. Expression data are provided relative to GAPDH for the same samples on the same gels.
Data analysis
Clampfit 10.4 (Axon Instruments), GraphPad Prism 5.0, SigmaPlot 11.0, SigmaStat 3.1 and Quantity One 1-D software (Bio-Rad Laboratories, Hercules, CA, USA) were used for data analysis. All data are expressed as mean ± SEM. Multiple group comparisons were obtained with one-way ANOVA for non-repeated analyses in experiments involving more than two groups and two-way repeated-measures ANOVA for all multigroup analyses involving repeated measures. Individual-mean comparisons by Bonferroni-corrected t tests were obtained to identify the statistical significance of individual-mean differences when overall group effects were noted. A two-tailed P < 0.05 was considered statistically significant.
Results
c-Kit + eCPCs in adult dog hearts
Freshly isolated c-Kit + eCPCs had a homogeneous round-shaped morphology with a membrane capacitance of 5.5 ± 0.4 pF (n/N = cells/dogs = 53/17). Immunostaining confirmed the c-Kit positivity of purified eCPCs (Fig. 1A, left panel) and the c-Kit negativity of a comparator population (unsorted non-myocyte cell fraction; Fig. 1A, right panel) . We assessed the expression profiles of genes characteristic of eCPCs (KIT), cardiac fibroblasts (DDR2), endothelial cells (CD31), haematopoietic lineage cells (CD34 and CD45) and mesenchymal-derived cells (CD90 and CD105), before and after magnetic sorting. Figure 1B shows that KIT mRNA was enriched > 20-fold, whereas DDR2, CD31, CD34, CD45, CD90 and CD105 expression was negligible after the sorting procedure. These results confirm that our isolation protocol yields highly enriched and relatively pure c-Kit + cardiac cells.
Endogenous ion currents in freshly isolated c-Kit
In freshly isolated c-Kit + eCPCs, ion currents were minimal when Ca 2+ i was buffered in tight-seal patch mode ( Fig. 2A and B) . Perforated patch-clamp recording, which preserves intracellular macromolecules and divalent cations such as Ca 2+ and Mg 2+ , revealed robust outward currents displaying inward rectification and a reversal potential (E rev ) of −78 ± 12 mV (Fig. 2C) . The inclusion of 300 nmol l −1 Ca 2+ (free concentration) in tight-seal patch pipettes revealed a prominent inwardly rectifying voltage-independent current ( Fig. 2A and B) with an E rev of −93 ± 2 mV (Fig. 2D) . Figure 2E shows the resting membrane potential (V mem (Zhang et al. 2014) , we tested the response to the selective BKCa blocker paxilline. Paxilline had no effect on the current density (Fig. 3B) . Based on the biophysical properties of the current and the fact that the intermediate-conductance Ca 2+ -dependent K + channel (SK4; KCa3.1) has been reported in several non-excitable cells including stem cells from various origins, we then tested the response to KCa3.1 blockers. We found that TRAM-34 and maurotoxin (MTX) strongly inhibited the current (Fig. 3C ).
Ion channel subunit gene expression in freshly isolated c-Kit
+ eCPCs Figure 4A and B shows K + channel subunit expression in eCPCs relative to the unsorted non-myocyte cell fraction from the same animals. Most voltage-dependent and inwardly rectifying K + channel subunits were weakly expressed in freshly isolated c-Kit + eCPCs. The only subunit showing significantly greater expression in eCPCs versus unsorted comparator cells was the KCa3.1 channel encoding gene KCNN4, in agreement with our patch-clamp data. Heart diseases and cardiovascular risk factors are associated with accelerated ageing of progenitor cells. Evidence in the literature suggests that heart failure promotes cardiac progenitor cell senescence, which might impair their regenerative potential (Zakharova et al. 2013) . We therefore assessed KCa3.1 expression in c-Kit + eCPCs freshly isolated from the hearts of CHF dogs. All dogs in the CHF group showed pulmonary congestion and pericardial effusion during open-chest study. Arterial systolic pressures were lower in CHF dogs compared to controls, and left ventricular (LV) end-diastolic, left atrial (LA) and right atrial (RA) pressures were higher (Table 1) . Freshly isolated CHF c-Kit + eCPCs were smaller than control cells (4.2 ± 0.5 pF vs. 5.5 ± 0.4 pF, P < 0.05), and V mem of c-Kit + eCPCs was depolarized in CHF versus control dogs under perforated-patch conditions (−58 ± 7 mV vs. −73 ± 3 mV, P < 0.05). Consistent with the observed difference in V mem , TRAM-34-sensitive current was significantly reduced in c-Kit + eCPCs from CHF dog hearts (Fig. 5A ). Reduced expression levels of KCNN4 mRNA and corresponding protein were confirmed ( Fig. 5B and C) . Population doubling time measurements revealed that CHF c-Kit + eCPCs proliferate more slowly than control cells (Fig. 5D) . Western blot demonstrated lower expression of cyclin E2 in CHF c-Kit + eCPCs (Fig. 5E ). These results suggest that reduced I KCa3.1 density and associated V mem depolarization might contribute to perturbed cellular function of c-Kit + eCPCs in CHF. blue symbols). Under Ca 2+ i depletion, currents are negligible; they are greatly enhanced by SOCE and substantially reduced by TRAM-34. These observations confirm a highly significant reduction in currents during SOCE with I KCa3.1 inhibition. To verify the consequences, we performed current-clamp recording of V mem under conditions that elicited SOCE (Fig. 6B) . In the presence of very low intracellular [Ca 2+ ] resulting from perfusion with nominally Ca 2+ -free extracellular solution, V mem was about −20 mV. Following store depletion, the addition of 1.8 mmol l −1 extracellular Ca 2+ induced a strong hyperpolarization (from −21 ± 4 mV to −79 ± 7 mV in 46 cells, P < 0.001). The addition of TRAM-34 during SOCE strongly attenuated this hyperpolarization, as shown by the V mem changes in Fig. 6B and indicated by the mean V mem values in Fig. 6C . SOCE inhibition by 2-aminoethoxydiphenyl borate (2-APB) also attenuated the hyperpolarization produced by exposure to 1. (Fig. 6C) . These results indicate that I KCa3.1 maintains a negative transmembrane potential during SOCE in eCPCs, thus ensuring the driving force for Ca 2+ entry. To directly assess the notion that I KCa3.1 might facilitate Ca 2+ entry in eCPCs by maintaining the electrical gradient for inward Ca 2+ movement, we monitored changes in [Ca 2+ ] i by microfluorometry/confocal microscopy. Figure 7A shows representative Fluo-4 images acquired before and during SOCE, in the presence or absence of the KCa3.1 blocker TRAM-34. SOCE caused clear increases in [Ca 2+ ] i (lower left panel), largely attenuated by TRAM-34 (lower right). Mean data in Fig. 7B show that TRAM-34 substantially decreased the [Ca 2+ ] i increase during SOCE in c-Kit + eCPCs.
To rule out any non-specific effects of TRAM-34 on Ca 2+ dynamics and V mem , we next studied [Ca 2+ ] i and V mem following KCNN4 gene knockdown in c-Kit + eCPCs. Mean data in Fig. 8A show that KCNN4 mRNA was decreased by 69 ± 12% 48 h after siRNA delivery. Patch-clamp experiments showed a significant reduction in TRAM-34-sensitive current for c-Kit + eCPCs transfected with KCNN4-siRNAs compared to control (Fig. 8B) , and consistent with our previous observations, a more depolarized V mem (Fig. 8C) . We then assessed [Ca 2+ ] i by microfluorometry. Figure 8D shows representative Fluo-4 images acquired under basal conditions, with and without KCNN4 gene knockdown. Reducing I KCa3.1 density by gene knockdown clearly decreased basal [Ca 2+ ] i (Fig. 8E ). Taken altogether, these results indicate that normal eCPC Ca 2+ signalling depends on I KCa3.1 activity.
Regulation of Ca 2+ signalling in extra-cardiac stem cells
To determine whether our observations regarding the role of KCa3.1 are specific to eCPCs or might apply more broadly to stem and progenitor cells, we examined a stem cell population of extra-cardiac origin, BM-MSCs. Canine BM-MSCs expressed TRAM-34-sensitive current (Fig. 9A ). BM-MSCs had a resting potential of about −70 mV, and were strongly depolarized by blocking I KCa3.1 (Fig. 9B) . Figure 9C addition of TRAM-34 during SOCE strongly attenuated this hyperpolarization, as shown by the V mem changes in Fig. 9C and indicated by the mean V mem values in Fig. 9D . SOCE-inhibition by 2-APB attenuated the hyperpolarization produced by exposure to 1.8 mmol l (Fig. 9D) . To assess the role of I KCa3.1 in controlling Ca 2+ entry in BM-MSCs, we monitored changes in [Ca 2+ ] i by confocal microscopy. Figure 10A shows representative Fluo-4 images acquired before and during SOCE, in the presence or absence of the KCa3.1 blocker TRAM-34. SOCE caused clear increases in [Ca 2+ ] i (lower left panel), significantly attenuated by TRAM-34 (lower right). As observed for c-Kit + eCPCs, treatment of BM-MSCs with TRAM-34 substantially decreased the level of [Ca 2+ ] i increase during SOCE (Fig. 10B) , indicating that BM-MSC Ca 2+ signalling depends on I KCa3.1 activity.
Functional role of I KCa3.1 in proliferation of stem and progenitor cells in vitro
Ca
2+ entry is required for progression through G1 and for the G1/S transition in several cell types, including human embryonic lung fibroblasts (Hazelton et al. 1979; Tupper et al. 1980) and L1210 leukaemic cells (Cory et al. 1987) . Because Ca 2+ entry is also an important signal for eCPC growth (Ferreira-Martins et al. 2009) proliferation in vitro. Before initiating proliferation assays, we confirmed that expanded c-Kit + eCPCs (passages 2-4) express KCa3.1 current and KIT mRNA at levels similar to those in freshly isolated cells (Fig. 11A and B) .
Cells were then incubated for 48 h in the presence of TRAM-34 or siRNA molecules (c-Kit + eCPCs only). Treatment with TRAM-34 significantly increased both c-Kit + eCPC and BM-MSC population doubling time ( Fig. 12A and B) . I KCa3.1 knockdown in c-Kit + eCPCs also significantly increased doubling time (Fig. 12C) , albeit less effectively than the larger concentration of TRAM-34 (presumably because the effect of 69% KCNN4 knockdown on the current was less intense than current blockade with 10 μmol l −1 TRAM-34). To gain insight into the molecular mechanisms by which KCa3.1 regulates stem and progenitor cell proliferation, we examined the expression levels of cell cycle regulatory proteins (i.e. cyclin D and cyclin E2). Pharmacological inhibition of KCa3.1 with TRAM-34 significantly decreased mRNA expression levels of cyclin E2 and protein expression levels of both cyclin D1 and E2 in c-Kit + eCPCs ( Fig. 13A and B) . KCa3.1 knockdown in c-Kit + eCPCs produced similar effects to TRAM-34 ( Fig. 13C ; note that because of the small number of cells available in these knockdown studies we were unable to perform immunoblots for this experiment). In BM-MSCs, both mRNA and protein expression levels of cyclin D1 and E2 were downregulated after TRAM-34 treatment ( Fig. 13D and E) . These results indicate a clear role for KCa3.1 regulation of V mem and associated maintenance of Ca 2+ signalling for cycle progression and proliferation of stem and progenitor cells.
Discussion
In this study, we found that c-Kit + eCPC membrane potential is critically dependent on KCa3.1 channel function. During SOCE, Ca 2+ entry depolarizes the cell unless there is a countervailing current response. KCa3.1 channels are opened by Ca 2+ ions, playing a crucial role in eCPC Ca 2+ signalling by maintaining (and in fact enhancing) the driving force for Ca 2+ entry under SOCE, thus amplifying the effect of the Ca 2+ signal and contributing to c-Kit + eCPC proliferation. We also show that KCa3.1 channels play a similar role in stem cells sourced from bone marrow and that eCPC KCa3.1 channels are downregulated in cardiac disease.
Control of c-Kit
+ eCPC membrane potential and Ca 2+ entry by KCa3.1 channels
In various excitable and non-excitable cell types, many K + channels have been implicated in regulating the membrane potential. In contrast to other cardiac cells such as cardiomyocytes (Chilton et al. 2005) and fibroblasts (Qi et al. 2015) , the membrane potential of freshly isolated eCPCs is not set by Kir channels. We found that the resting membrane potential of c-Kit + eCPCs depends predominantly on the intermediate-conductance Ca 2+ -activated channel KCa3.1. Activation of KCa3.1 induces membrane hyperpolarization, thus increasing the driving force for Ca 2+ entry through store-operated channels. This type of relationship between K + channels, membrane potential and Ca 2+ influx is reminiscent of phenomena reported in immune-mediating T-cells by Hess et al. (1993) and in melanoma cells, where membrane hyperpolarization increased [Ca 2+ ] i by controlling the electrochemical gradient for Ca 2+ entry into the cell (Nilius & Wohlrab, 1992) .
Functional role of KCa3.1 channels and SOCE in stem and progenitor cells Ca 2+ signalling is a tightly regulated control mechanism in many cell types that can be modulated in amplitude, duration and frequency by different stimuli (Berridge et al. 2003; Clapham, 2007) . It was recently demonstrated that Ca 2+ influx through SOCE channels promotes migration and proliferation of human c-Kit + cardiac progenitors in vitro by modulating cell cycle regulatory proteins (cyclin D1 and E) and Akt signalling (Che et al. 2015) . c-Kit + cardiac progenitor cell growth is regulated by spontaneous intracellular Ca 2+ oscillations that can be triggered by ATP, histamine and IGF-1 in an IP 3 -dependent manner (Ferreira-Martins et al. 2009 ). There is evidence that Ca 2+ -activated K + channel blockers regulate cell function and fate in MSCs (Tao et al. 2008 ) and induced pluripotent stem cells (Kleger et al. 2010) , although the underlying ionic mechanisms have not been addressed. It is known that cyclins and cyclin-dependent kinase (CDK) complexes are regulated by calcium influx in some cell types (Tomono et al. 1998; Mignen et al. 2003) . KCa3.1 blockers decrease proliferation of MSCs by modulating cyclin D1 and E2 expression, although the physiological basis for this has not been elucidated (Tao et al. 2008) . Here, we found that KCa3.1 plays a critical role in SOCE and that inhibiting it decreases the expression of cyclin E2 in c-Kit + eCPCs. Our results point to KCa3.1 regulation of V mem as a crucial determinant of stem-and progenitor-cell Ca 2+ homeostasis and proliferation.
Novel elements
Our study provides the first characterization of ion current expression profiles in freshly isolated c-Kit + eCPCs and identifies KCa3.1 as a novel and potentially important regulator of c-Kit + eCPC V mem and function. In the adult myocardium, c-Kit + eCPCs may be connected to surrounding cardiomyocytes and fibroblasts by gap J Physiol 596.12 and adherent junctions (Bearzi et al. 2007 (Bearzi et al. , 2009 ). The electrical properties of c-Kit + eCPCs are important for their function, as we show here, and could be subject to modulation by adjacent cells of other types.
The pool of c-Kit + eCPCs is enhanced acutely after myocardial infarction, but this growth response is attenuated in CHF, arguing that CHF might have deleterious effects on c-Kit + eCPC physiology (Urbanek et al., 2005a, b) . Our results suggest that the impaired proliferative capacity of CHF c-Kit + eCPCs might be due to downregulation of KCa3.1 and its adverse effects on cellular Ca 2+ -signalling.
Potential significance
Division of c-Kit + eCPCs is promoted by spontaneous Ca 2+ oscillations, and c-Kit + eCPC differentiation appears to contribute to cardiomyogenesis during embryonic and fetal life (Ferreira-Martins et al. 2012) . Loss of c-Kit + eCPC function promotes cardiomyocyte ageing and emergence of a senescent phenotype Gonzalez et al. 2008) . A variety of cardiac conditions (e.g. diabetes, obesity, cardiac overload, medications and ageing) impair c-Kit + eCPC function and promote cellular senescence (Torella et al. 2004; Anversa et al. 2005; Frati et al. 2011; Kurazumi et al. 2011; Leonardini & Avogaro, 2013) . Nevertheless, questions remain about their physiological role and relevance in adult hearts. Recently, Di Siena et al. (2016) showed that constitutive activation of c-Kit receptor is associated with an increased cardiac myogenic and vasculogenic reparative potential after injury These results point towards a significant role of endogenous c-Kit + eCPCs in cardiac repair, homeostasis and survival. Although activation of c-Kit + eCPCs follows myocardial injury, the intrinsic ability of the myocardium to self-renew does not compensate for the massive loss of cardiomyocytes observed in severe pathologic conditions such as acute myocardial infarction or heart failure (Beltrami et al. 1994; Linke et al. 2005; Anversa et al. 2006; Urbanek et al., 2005a, b) . From a therapeutic point of view, ex vivo proliferated c-Kit + eCPCs have emerged as an attractive candidate for cell-based regenerative therapy. Preclinical (Dawn et al. 2005; Tang et al. 2010; Bolli et al. 2013) and clinical ) studies have been encouraging, although there is controversy regarding the precise mechanisms by which c-Kit + eCPCs improve cardiac function following direct transplantation into the damaged heart.
The potency of transplanted cells and the availability of an adequate cell number are the most relevant among key factors for the success of cell therapy in treating heart disease (D' Amario et al. 2011) . Recently, it has been shown that patient co-morbidities limit the ability of cardiac explant-derived progenitor cells to repair injured hearts in experimental animal models (Mayfield et al. 2016) . Cell therapy effectiveness varies greatly and approaches that would improve treatment efficacy/reliability would be highly desirable. A variety of molecular and cellular preconditioning strategies have been proposed to address the heterogenous cardiac reparative proficiency of patient-derived stem cell products (Yu et al. 2013) .
Our findings raise the possibility that modulating KCa3.1 expression or function (e.g. by KCa3.1 gene transfer) might be useful to improve the therapeutic potential of c-Kit + eCPCs in cardiac cell therapy. KCa3.1 channel expression might also serve as a biomarker to identify progenitor cell sub-populations with higher proliferative capacity. Finally, we have shown the generalizability of the importance of KCa3.1 to BM-MSCs, another promising cell product being developed for cardiac regenerative therapy. Our work thus provides new insights of conceptual and potential therapeutic significance into the fundamental determinants of progenitor cell function and disease-induced dysfunction.
Limitations
We studied cell proliferation during in vitro expansion, while ion currents were defined and characterized in freshly isolated cells. However, maintained expression of KCa3.1 in cultured cells was confirmed before initiating proliferation assays. The density of I KCa3.1 was similar between freshly isolated and expanded cells (passages 2-4). Although cultured c-Kit + eCPCs represent a useful model to study the role of KCa3.1 channels in cell proliferation, the involvement of KCa3.1 in c-Kit + eCPCs proliferation might be underestimated because of the potential emergence of other types of functional ion channels during in vitro amplification. It would be of interest to compare KCa3.1 expression in freshly isolated eCPCs with cultured eCPCs derived from later passages, because c-Kit + eCPCs that are utilized in cell therapy are passaged at least five times to ensure the availability of a sufficiently large number of cells for adoptive transfer.
While we noted significant changes in c-Kit + eCPC KCa3.1 expression and current with CHF, Zhang et al. (2014) noted no differences in ion channel expression profile in cells from patients with different ages, diseases and medications. Previous work has shown that both electrophysiological and functional differences between freshly isolated control and CHF atrial cardiac fibroblasts are obscured by the effects of cell culture (Dawson et al. 2012) . It would have been instructive to determine whether KCa3.1 overexpression can improve the proliferative function of CHF c-Kit + eCPCs. We did attempt such studies; however, we were unsuccessful in obtaining adequate KCa3.1 protein overexpression with a commercially available lentivirus construct containing the human KCNN4 gene.
We used pharmacological tools extensively in this study. The concentrations that we used were based on prior information in the literature. TRAM-34 is a potent and highly selective blocker of KCa3.1 channels with 200-to 1500-fold selectivity over Kv, BKCa, KCa2, Na + , CRAC and Cl − channels (Wulff et al. 2000; Köhler et al. 2003) . Full block of KCa3.1 current is seen in the low micromolar range (Köhler et al. 2003) . MTX blocks KCa3.1 in the nanomolar concentration range, but has no effect on KCa1.1, KCa2.1, KCa2.2 or KCa2.3 small-conductance KCa channels up to 1 μmol l −1 (Castle et al. 2003) . 2-APB inhibits SOCE half-maximally at 30 μmol l -1 and completely at 250 μmol l −1 (Martín-Romero et al. 2008) . As a complement to the pharmacological studies to exclude the role of potential off-target effects, we repeated key experiments with siRNA-based genetic knockdown of KCa3.1, showing that it reduced the corresponding current (Fig. 8B) , c-Kit + CPC resting membrane potential (Fig. 8C) and SOCE-mediated Ca 2+ entry (Fig. 8E) , as well as increasing cultured c-Kit + CPC doubling time (Fig. 12C) .
Conflicting results have been obtained with respect to the cardiomyogenic potential of c-Kit + eCPCs in adult hearts. Initial reports of significant in situ differentiation into cardiomyocytes (Beltrami et al. 2003; Wu et al. 2006; Ferreira-Martins et al. 2012) have not been reproduced by other laboratories (Zaruba et al. 2010; Sturzu & Wu, 2011; van Berlo et al. 2014) , suggesting that functional improvement resulting from c-Kit + eCPCs might be due to paracrine mechanisms. Sultana et al. (2015) reported that c-Kit predominantly labels a mature cardiac endothelial cell population in developing and adult hearts rather than eCPCs, supporting the low cardiomyogenic potential of endogenous c-Kit + cardiac cells. Moreover, the microenvironment in post-ischaemic and failing hearts may compromise eCPC regenerative potential. Indeed, Hamid et al. (2016) found that elevated tumor necrosis factor-α receptor signalling restrains cardiomyocyte differentiation of resident eCPCs and promotes adverse cardiac remodeling. Irrespective of the precise role of c-Kit + eCPCs in cardiac physiology, their potential usefulness in cell therapy impels efforts to improve our understanding of the determinants of their function. Furthermore, the similar role of KCa3.1 that we noted in c-Kit + eCPCs and BM-MSCs argues for a potentially generalizable principle in stem cell physiology.
Conclusions
KCa3.1 channels provide the principal conductance determining cell membrane polarization in eCPCs and BM-MSCs, and are essential for normal SOCE and proliferative properties. Cardiac disease downregulates eCPC KCa3.1 channels and impairs KCa3.1 channel function. These findings provide new insights into the basic determinants of stem and progenitor cell physiology with potential relevance to improving cell and regenerative therapy for heart disease.
